Want to join the conversation?
$ABBV said argenx will conduct research and development through IND-enabling studies. Upon successful completion of these studies, $ABBV may exercise an exclusive option to license the ARGX-115 program and assume responsibility for further clinical development and commercialization.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?